Monique Claudon

In vitro activity of the  -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

Therese‐Marie Stachyra, Premavathy Levasseur, Marie-Claude Péchereau et al. · Journal of Antimicrobial Chemotherapy · 2009 · 171 citations · Full text

Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

Michael T. Black, Therese‐Marie Stachyra, Denis Platel et al. · Antimicrobial Agents and Chemotherapy · 2008 · 141 citations · Full text

Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor

Therese‐Marie Stachyra, Marie-Claude Péchereau, Jean‐Michel Bruneau et al. · Antimicrobial Agents and Chemotherapy · 2010 · 140 citations · Full text

Mechanistic Studies, Antimicrobial Chemotherapy, Chemical Biology +16

<i>In Vitro</i> Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates

Premavathy Levasseur, Anne-Marie Girard, Monique Claudon et al. · Antimicrobial Agents and Chemotherapy · 2012 · 101 citations · Full text

The &amp;beta;-lactamase inhibitor avibactam (NXL104) does not induce ampC &amp;beta; -lactamase in Enterobacter cloacae

Christine Miossec, Monique Claudon, Premavathy Levasseur et al. · Infection and Drug Resistance · 2013 · 19 citations · Full text